Middle East and Africa Neuromodulation Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis by Technology (External (Non-Invasive) Neuromodulation, and Internal Neuromodulation); Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine); End User (Hospitals, Clinics, and Home Healthcare) and Geography

No. of Pages: 113
Report Code: TIPRE00016325
Category: Life Sciences
Middle East and Africa Neuromodulation Market
Buy Now

Market Introduction

Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.

Market Overview and Dynamics

The Middle East & Africa Neuromodulation market is projected to reach US$  834.67 million by 2027 from US$  410.80 million in 2019; it is estimated to grow with a CAGR of 9.6% from 2020 to 2027. The growth of the Middle East & Africa neuromodulation market is attributed to the increasing incidence of neurological disorders, growing developments in neuromodulation technology. However, high cost of neuromodulation devices the growth of market in this region. leading to restraining the growth of the market.

Key Market Segments

Based on technology, the Middle East & Africa neuromodulation market is segmented into external (non-invasive) neuromodulation and internal neuromodulation. In 2019, the internal neuromodulation segment held a larger share of the market. External (non-invasive) neuromodulation is expected to grow at a faster rate during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred to while preparing the Middle East & Africa neuromodulation market report are World Health Organization, Ministry of Health & Prevention, Parkinson’s Disease & Movement Disorder Society (PDMDS), and Garvan Institute, and Ministry of Health and Family Welfare.

Abbott, Boston Scientific Corporation, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., NEVRO CORP, Synapse Biomedical Inc., Soterix Medical Inc, Integer Holdings Corporation, and Magstim.

 

Reasons to buy the report

  • To understand the Middle East & Africa neuromodulation market landscape and identify market segments that are most likely to guarantee a strong return
  • To stay ahead in comprehending the ever-changing competitive landscape of the Middle East & Africa neuromodulation market
  • To efficiently plan M&A and partnership deals in the Middle East & Africa neuromodulation market by identifying market segments with the most promising probable sales
  • To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Middle East & Africa neuromodulation market
  • To obtain market revenue forecast from 2019 to 2027 in various segments of the Middle East & Africa neuromodulation market

MIDDLE EAST & AFRICA NEUROMODULATION MARKET SEGMENTATION

By Technology

  • External (Non-Invasive) Neuromodulation
    • Respiratory Electrical Stimulation
    • Transcutaneous Electrical Nerve Stimulation
    • Transcranial Magnetic Stimulation
  • Internal Neuromodulation
    • Deep Brain Stimulation
    • Sacral Nerve Stimulation
    • Gastric Electrical Stimulation
    • Spinal Cord Stimulation
    • Vagus Nerve Stimulation

By Application

  • Chronic Pain Management
  • Failed Back Syndrome
  • Epilepsy
  • Tremor
  • Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Obsessive-Compulsive Disorder
  • Migraine

 

By End User

  • Hospitals
  • Clinics
  • Home Healthcare

 

By Country

  • Saudi Arabia
  • South Africa
  • UAE
  • RoMEA

 

Company Profiles

  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc
  • Integer Holdings Corporation
  • Magstim
 

Middle East and Africa Neuromodulation Market Strategic Insights

global-market-strategic-framework
Get more information on this report

Middle East and Africa Neuromodulation Market Segmentation Analysis

Middle East and Africa Neuromodulation Market Report Highlights

Middle East and Africa Neuromodulation Report Scope

Report Attribute Details
Market size in 2019 US$ 410.80 Million
Market Size by 2027 US$ 834.67 Million
CAGR (2020 - 2027) 9.6%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Technology
  • External Neuromodulation
  • Internal Neuromodulation
By Application
  • Chronic Pain Management
  • Failed Back Syndrome
  • Epilepsy
  • Tremor
  • Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson's Disease
  • Obsessive-Compulsive Disorder
  • Migraine
By End User
  • Hospitals
  • Clinics
  • Home Healthcare
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc
  • Integer Holdings Corporation
  • Magstim
Get more information on this report

Middle East and Africa Neuromodulation Market Country and Regional Insights

middle-east-and-africa-neuromodulation-market
Get more information on this report
Identical Market Reports with other Region/Countries

The List of Companies - Middle East and Africa Neuromodulation Market

  • <p style="line-height: 150%; margin: 0in 0in 8pt; font-size: 11pt; font-family: Calibri, sans-serif;"><strong><span style="font-size: 10.0pt; line-height: 150%; font-family: Verdana, sans-serif; color:
  • 1f4e79;">The List of Companies - Middle East and Africa Neuromodulation Market</span></strong></p><ol style="margin-top: 0in; margin-bottom: .0001pt;"><li style="margin: 0in 0in 0.0001pt 24px; text-align: justify; line-height: 150%; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-size: 10.0pt; line-height: 150%; font-family: Verdana, sans-serif;">Abbott</span></li><li style="margin: 0in 0in 0.0001pt 24px; text-align: justify; line-height: 150%; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-size: 10.0pt; line-height: 150%; font-family: Verdana, sans-serif;">Boston Scientific Corporation</span></li><li style="margin: 0in 0in 0.0001pt 24px; text-align: justify; line-height: 150%; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-size: 10.0pt; line-height: 150%; font-family: Verdana, sans-serif;">Medtronic</span></li><li style="margin: 0in 0in 0.0001pt 24px; text-align: justify; line-height: 150%; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-size: 10.0pt; line-height: 150%; font-family: Verdana, sans-serif;">NeuroPace, Inc.</span></li><li style="margin: 0in 0in 0.0001pt 24px; text-align: justify; line-height: 150%; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-size: 10.0pt; line-height: 150%; font-family: Verdana, sans-serif;">NeuroSigma, Inc.</span></li><li style="margin: 0in 0in 0.0001pt 24px; text-align: justify; line-height: 150%; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-size: 10.0pt; line-height: 150%; font-family: Verdana, sans-serif;">NEVRO CORP.</span></li><li style="margin: 0in 0in 0.0001pt 24px; text-align: justify; line-height: 150%; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-size: 10.0pt; line-height: 150%; font-family: Verdana, sans-serif;">Synapse Biomedical Inc.</span></li><li style="margin: 0in 0in 0.0001pt 24px; text-align: justify; line-height: 150%; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-size: 10.0pt; line-height: 150%; font-family: Verdana, sans-serif;">Soterix Medical Inc</span></li><li style="margin: 0in 0in 0.0001pt 24px; text-align: justify; line-height: 150%; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-size: 10.0pt; line-height: 150%; font-family: Verdana, sans-serif;">Integer Holdings Corporation</span></li><li style="margin: 0in 0in 0.0001pt 24px; text-align: justify; line-height: 150%; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-size: 10.0pt; line-height: 150%; font-family: Verdana, sans-serif;">Magstim</span></li></ol><p style="margin: 0in 0in 8pt; line-height: 107%; font-size: 11pt; font-family: Calibri, sans-serif;">&nbsp;</p>
Frequently Asked Questions
How big is the Middle East and Africa Neuromodulation Market?

The Middle East and Africa Neuromodulation Market is valued at US$ 410.80 Million in 2019, it is projected to reach US$ 834.67 Million by 2027.

What is the CAGR for Middle East and Africa Neuromodulation Market by (2020 - 2027)?

As per our report Middle East and Africa Neuromodulation Market, the market size is valued at US$ 410.80 Million in 2019, projecting it to reach US$ 834.67 Million by 2027. This translates to a CAGR of approximately 9.6% during the forecast period.

What segments are covered in this report?

The Middle East and Africa Neuromodulation Market report typically cover these key segments-

  • Technology (External Neuromodulation, Internal Neuromodulation)
  • Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease, Obsessive-Compulsive Disorder, Migraine)
  • End User (Hospitals, Clinics, Home Healthcare)

What is the historic period, base year, and forecast period taken for Middle East and Africa Neuromodulation Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Neuromodulation Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
    • Who are the major players in Middle East and Africa Neuromodulation Market?

    The Middle East and Africa Neuromodulation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc
  • Integer Holdings Corporation
  • Magstim
    • Who should buy this report?

    The Middle East and Africa Neuromodulation Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East and Africa Neuromodulation Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now

    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)